Young Bo Sim MD

About The Author

Young Bo Sim MD

Dr. Young Bo Sim, MD, is a pediatrician and a fellow in pediatric cardiology at UCLA Mattel Children’s Hospital. He earned his medical degree from the Robert Larner M.D. College of Medicine at the University of Vermont. Dr. Sim is a clinical writer and researcher whose work spans diverse topics across general medicine, healthcare education, and pediatric specialties.

Gynecomastia: What Is It? Who Does It Affect? Is It Treatable?

Health Condition, Health News, Plastic Surgery

Gynecomastia is a condition that makes it difficult for a man to live his life without being extremely self-conscious of his physique. This article will discuss the symptoms, causes, …

[Continue Reading...]

Is NAD+ The Anti Aging Substance Mankind Has Been Searching For?

Anti Aging, Health News

The Current Market The anti-aging market is currently a huge multi-billion dollar industry, with products and services ranging from lotions, creams, laser treatments, facials, medications etc. Everyone, whether they …

[Continue Reading...]

Common Painkiller Diclofenac Linked with Increased Cardiovascular Risk

Archives

Diclofenac Diclofenac, a commonly used painkiller, has been found to potentially be linked to an increased risk of cardiovascular problems in a large Danish study. Diclofenac is a non-steroidal …

[Continue Reading...]

Rising Teen HGH Usage A Growing Concern

Archives

Teen Growth Hormone Usage Rising Performance-enhancing drugs (PEDs) have been a topic of much debate amongst professionals in multiple fields, involving legal, medical, and even ethical issues. Although many …

[Continue Reading...]

CRISPR Base Editing Treats Genetic Liver Disease in Mice Before Birth

Archives

Key Takeaways: Researchers successfully used CRISPR base editing to correct a lethal liver disease (hereditary tyrosinemia type I) in mouse fetuses, with effects lasting into adulthood. Unlike traditional CRISPR, …

[Continue Reading...]

Gilead’s Hepatitis C Treatment Is Now More Affordable

Archives

Gilead HCV Treatment News It was reported by officials of Gilead Sciences, Inc. in a recent press release that they were going to create a new subsidiary, Asequa Therapeutics …

[Continue Reading...]